Apr. 13 at 1:13 PM
$GS $FAST $ALMU $RVMD $IDYA
PRE-MARKET MOVERS:
Currently Higher:
- Allogene Therapeutics (ALLO) up 62.9% after reporting data from the planned interim futility analysis of its randomized Phase 2 ALPHA3 trial
- Revolution Medicines (RVMD) up 39.5% after announcing topline results from its controlled Phase 3 RASolute 302 clinical trial
- Aeluma (ALMU) up 23.3% after being awarded over
$4M in government contracts for quantum materials, lasers
- Ideaya Biosciences (IDYA) up 14.8% after announcing topline results from OptimUM-02 trial
- Leggett & Platt (LEG) up 8.5% after Somnigroup (SGI) and the company announced that the companies have signed a definitive agreement pursuant to which Somnigroup will acquire Leggett & Platt in an all-stock transaction valued at approximately
$2.5B
- Williams-Sonoma (WSM) up 3.1% after Goldman Sachs upgraded the stock to Buy from Neutral with a price target of
$218, up from
$185
- Baker Hughes (BKR) up 1.4% after announcing that it has entered into an agreement to sell its Waygate Technologies business to Hexagon (HXGBY)
- Toll Brothers (TOL) up 1.3% after Evercore ISI upgraded shares to Outperform from In Line with a price target of
$176, up from
$174
Currently Lower After Earnings:
- Goldman Sachs (GS) down 4.3%
- Fastenal (FAST) down 1.8%
Currently Also Lower:
- Best Buy (BBY) down 4.4% after Goldman Sachs double downgraded the stock to Sell from Buy with a price target of
$59, down from
$76
- Somnigroup (SGI) down 1.7% after the company and Leggett & Platt announced that the companies have signed a definitive agreement pursuant to which Somnigroup will acquire Leggett & Platt in an all-stock transaction valued at approximately
$2.5B
